Shenzhen-based Lonvi Biosciences introduced a capsule made from grape seed extract that it claimed could extend human life to 150 years. “Living to 150 years is definitely realistic. In a few years, it will become a reality,” said Chief Technology Officer Liu Qinghua, according to a report by RBC.
The company stated that laboratory mice given the formulation lived 9.4 percent longer overall and 64.2 percent longer from the first day of treatment. The tablets concentrate procyanidin C1 (PCC1), a molecule isolated from grape seeds that earlier research in Shanghai linked to longer survival in rodents. Lonvi Biosciences said the compound destroys “zombie cells” — aged cells that no longer divide but continue to trigger inflammation — while sparing healthy tissue.
“This is not just another pill. This is the Holy Grail,” said Chief Executive Officer Ip Zhu, Diario Popular wrote. Company scientists argued that, combined with a healthy lifestyle and medical care, the capsules could allow people to live past 100 and possibly to 120.
Lonvi Biosciences opened its main laboratory in 2022, soon after the Shanghai team released its findings on PCC1. Zhu said progress in geroscience was advancing so rapidly that “it might at least be possible to postpone death,” adding that “within five to ten years, no one will suffer from cancer."
China’s government has made longevity research a national priority alongside artificial intelligence and biotechnology, according to a New York Times report. President Xi Jinping privately wondered whether people “may soon live to 150 years,” while Russian President Vladimir Putin told him that advanced organ-transplant methods could bring “immortality,” according to RBC and TASS. Microphones caught the two leaders discussing life-extension research during the Shanghai Cooperation Organization summit; CCTV asked that the footage be removed, RBC said.
Private firms have pursued similar goals. SuperiorMed said it runs the world’s largest longevity hospital in Chengdu and envisions future islands of immortality, though it acknowledged they do not yet exist. Rlab in Shanghai offers clients cryogenic chamber sessions at –129 °C to slow cellular deterioration, Diario Popular reported. Gan Yu, co-founder of the Shanghai start-up Time Pie, observed that “now many Chinese are interested and have the money needed to extend their lives,” the outlet wrote.
Lonvi Biosciences said its aim was not only to add years but to reduce age-related disease by strengthening health at the cellular level, Komsomolskaya Pravda reported. Whether the PCC1 capsule can match the gains seen in mice when used by humans remains unproven, yet the firm’s bold prediction has already drawn global interest.
Assisted by a news-analysis system.